This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kamiya, T. Articles by Terashi, A. Search for Related Content PubMed PubMed Citation Articles by Kamiya, T. Articles by Terashi, A.

Stroke, Vol 24, 571-575, Copyright © 1993 by American Heart Association

ARTICLES

The role of bradykinin in mediating ischemic brain edema in rats

T Kamiya, Y Katayama, F Kashiwagi and A Terashi
Second Department of Internal Medicine, Daiichi Hospital, Nippon Medical School, Tokyo.

BACKGROUND AND PURPOSE: We investigated the hypothesis that bradykinin generation may induce ischemic brain edema in spontaneously hypertensive rats. METHODS: Cerebral ischemia lasting 3 hours was produced by bilateral common carotid artery occlusion in 67 rats. After the ischemic period, the rats were reperfused. Cerebral water content and energy metabolites (adenosine triphosphate, lactate, and pyruvate), as well as plasma and tissue bradykinin, were measured. Additionally, using the same experimental paradigm, bradykinin synthesis inhibitors (aprotinin [n = 7] and soybean trypsin inhibitor [n = 7]) were administered immediately after ischemia induction to determine the relation of bradykinin generation to the progression of ischemic brain edema. RESULTS: Cerebral water content increased during the 3-hour ischemic period, peaked at 30 minutes of reperfusion, and declined thereafter. Bradykinin levels in plasma and tissue rose markedly 30 minutes after reperfusion and fell thereafter. The progressive loss of adenosine triphosphate was mirrored by the rise in lactate. In the treated groups, aprotinin and soybean trypsin inhibitor administration significantly attenuated cerebral edema (p < 0.01 and p < 0.05, respectively). The treated groups also showed less lactate accumulation and more adenosine triphosphate preservation than did the controls. CONCLUSIONS: These results demonstrate that bradykinin levels in plasma and tissue corresponded to cerebral edema progression and that bradykinin suppression decreased edema formation. These novel findings indicate that bradykinin activation augments the progression of ischemic brain edema.

This article has been cited by other articles:

				V. Anttila, I. Hagino, Y. Iwata, B. A. Mettler, H. G.W. Lidov, D. Zurakowski, and R. A. Jonas Aprotinin improves cerebral protection: Evidence from a survival porcine model J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 948 - 953. [Abstract] [Full Text] [PDF]

				C.-F. Xia, R. S. Smith Jr, B. Shen, Z.-R. Yang, C. V. Borlongan, L. Chao, and J. Chao Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor Hypertension, April 1, 2006; 47(4): 752 - 761. [Abstract] [Full Text] [PDF]

				P. J. Hess Jr. Systemic inflammatory response to coronary artery bypass graft surgery Am. J. Health Syst. Pharm., September 15, 2005; 62(18_Supplement_4): S6 - S9. [Abstract] [Full Text] [PDF]

				D. C. Harmon, K. G. Ghori, N. P. Eustace, S. J. F. O'Callaghan, A. P. O'Donnell, and G. D. Shorten Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study: [L'aprotinine reduit l'incidence de deficit cognitif a la suite d'un PAC et de la circulation extracorporelle : une etude pilote randomisee et controlee] Can J Anesth, December 1, 2004; 51(10): 1002 - 1009. [Abstract] [Full Text] [PDF]

				M. U. Norman, R. A. Lew, A. I. Smith, and M. J. Hickey Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1942 - H1948. [Abstract] [Full Text] [PDF]

				J. M. Murkin Adverse Central Nervous System Outcomes After Cardiopulmonary Bypass: A Beneficial Effect of Aprotinin? Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 282 - 285. [Abstract] [PDF]

				J. M. Murkin Strategies and Techniques for Neuroprotection in Coronary Artery Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 4 - 8. [Abstract] [PDF]

				H. P. Grocott, H. Sheng, Y. Miura, S. Sarraf-Yazdi, G. B. Mackensen, R. D. Pearlstein, and D. S. Warner The Effects of Aprotinin on Outcome from Cerebral Ischemia in the Rat Anesth. Analg., January 1, 1999; 88(1): 1 - 7. [Abstract] [Full Text] [PDF]

				I. Nagahiro, T. White, M. Yano, C. H.R. Boasquevisque, M. Hiratsuka, J. D. Cooper, and G. A. Patterson Recombinant kunitz protease inhibitor ameliorates reperfusion injury in rat lung transplantation Ann. Thorac. Surg., August 1, 1998; 66(2): 351 - 355. [Abstract] [Full Text] [PDF]

				J. K. Relton, V. E. Beckey, W. L. Hanson, and E. T. Whalley CP-0597, a Selective Bradykinin B2 Receptor Antagonist, Inhibits Brain Injury in a Rat Model of Reversible Middle Cerebral Artery Occlusion Stroke, July 1, 1997; 28(7): 1430 - 1436. [Abstract] [Full Text]

				K. A. Delaria, D. K. Muller, C. W. Marlor, J. E. Brown, R. C. Das, S. O. Roczniak, and P. P. Tamburini Characterization of Placental Bikunin, a Novel Human Serine Protease Inhibitor J. Biol. Chem., May 2, 1997; 272(18): 12209 - 12214. [Abstract] [Full Text] [PDF]